The recent direct-to-consumer/out-of-pocket strategies introduced by companies as lower cost options for their obesity medications, as well as more stringent payor/insurance coverage dynamics, could present some risk of even greater price erosion over the longer-term
Why are supermarkets changing portion sizes because of GLP-1 medications
It binds to toxins and helps the body move them out through normal elimination pathways
Mounjaro also sees substantial price differences, costing around $444 in the Netherlands and $319 in Japan, versus $1,023 in the US
BMI requirements were increased to greater than 40 mg/kg2 or greater than 35 mg/kg2 with one more weight-related comorbidity
53 The damage to structures such as the hippocampus could be due to silent brain hypoxia as well as an immune response against the virus, which can also affect the blood-brain barrier (BBB)